X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (28) 28
female (27) 27
middle aged (24) 24
adult (22) 22
male (19) 19
aged (18) 18
oncology (17) 17
cancer (13) 13
index medicus (11) 11
adolescent (10) 10
aged, 80 and over (9) 9
survival (9) 9
treatment outcome (9) 9
young adult (8) 8
chemotherapy (7) 7
metastasis (7) 7
prognosis (7) 7
retrospective studies (7) 7
disease-free survival (6) 6
neoplasm staging (6) 6
antineoplastic combined chemotherapy protocols - therapeutic use (5) 5
breast cancer (5) 5
neoplasms. tumors. oncology. including cancer and carcinogens (5) 5
surgery (5) 5
therapy (5) 5
carcinoma (4) 4
care and treatment (4) 4
case-control studies (4) 4
colorectal cancer (4) 4
kaplan-meier estimate (4) 4
metastases (4) 4
nivolumab (4) 4
pathology (4) 4
prognostic factors (4) 4
risk factors (4) 4
turkey (4) 4
adjuvant (3) 3
analysis (3) 3
analysis of variance (3) 3
angiogenesis (3) 3
breast neoplasms - pathology (3) 3
chemoradiotherapy (3) 3
chemotherapy, adjuvant (3) 3
diagnosis (3) 3
disease (3) 3
drug administration schedule (3) 3
experience (3) 3
immunotherapy (3) 3
ipilimumab (3) 3
l-lactate dehydrogenase - blood (3) 3
medicine & public health (3) 3
medicine, general & internal (3) 3
non-hodgkin's lymphoma (3) 3
patients (3) 3
radiotherapy, adjuvant (3) 3
risk assessment (3) 3
time factors (3) 3
abridged index medicus (2) 2
age (2) 2
anticardiolipin antibodies (2) 2
antimitotic agents (2) 2
antineoplastic agents (2) 2
antineoplastic agents - adverse effects (2) 2
antineoplastic agents - therapeutic use (2) 2
antineoplastic combined chemotherapy protocols - adverse effects (2) 2
biomarkers, tumor - blood (2) 2
bone (2) 2
bone metastasis (2) 2
bone neoplasms - pathology (2) 2
breast neoplasms - genetics (2) 2
cancer therapies (2) 2
carcinoma, non-small-cell lung - drug therapy (2) 2
cell survival (2) 2
chi-square distribution (2) 2
chronic disease (2) 2
coagulation (2) 2
colorectal neoplasms - mortality (2) 2
colorectal neoplasms - pathology (2) 2
d-dimer (2) 2
development and progression (2) 2
diagnosis, differential (2) 2
doxorubicin - administration & dosage (2) 2
endocrinology (2) 2
everolimus (2) 2
ewing's sarcoma family of tumors (2) 2
fibrinogen (2) 2
gastric cancer (2) 2
gastroenterology & hepatology (2) 2
hematology (2) 2
histology (2) 2
human genetics (2) 2
ifosfamide - administration & dosage (2) 2
internal medicine (2) 2
kinases (2) 2
level (2) 2
ligands (2) 2
liver neoplasms - secondary (2) 2
lung cancer (2) 2
lung cancer, non-small cell (2) 2
lung neoplasms - drug therapy (2) 2
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Lancet, The, ISSN 0140-6736, 2016, Volume 389, Issue 10066, pp. 255 - 265
Journal Article
by Mok, Tony and Mok, Tony S K and Wu, Yilong and Wu, Yi-Long and Kudaba, Iveta and Kowalski, Dariusz M and Kowalski, Dariusz and Cho, Byoung Chul and Turna, Hande and Turna, Hande Z and Castro, Hugo and Castro, Gilberto and Srimuninnimit, Vichien and Laktionov, Konstantin and Laktionov, Konstantin K and Bondarenko, Igor and Kubota, Kaoru and Lubiniecki, Gregory M and Zhang, Jin and Zhang, Li and Zhang, Xin and Kush, Debra and Lopes, Valeria and Lopes, Gilberto and Adamchuk, Grigory and Ahn, Myung-Ju and Alexandru, Aurelia and Altundag, Ozden and Alyasova, Anna and Andrusenko, Orest and Aoe, Keisuke and Araujo, Antonio and Aren, Osvaldo and Arrieta Rodriguez, Oscar and Ativitavas, Touch and Avendano, Oscar and Barata, Fernando and Barrios, Carlos Henrique and Beato, Carlos and Bergstrom, Per and Betticher, Daniel and Bolotina, Larisa and Botha, Michiel and Buddu, Sayeuri and Caglevic, Christian and Cardona, Andres and Cay Senler, Filiz and Cerny, Carlos Alexandre Sydow and Cesas, Alvydas and Chan, Gee-Chen and Chang, Jianhua and Chen, Xi and Chen, Gongyan and Cheng, Ying and Cheng, Susanna and Cherciu, Nelly and Chiu, Chao-Hua and Cicenas, Saulius and Ciurescu, Daniel and Cohen, Graham and Costa, Marcos Andre and Danchaivijitr, Pongwut and De Angelis, Flavia and de Azevedo, Sergio Jobim and Dediu, Mircea and Deliverski, Tsvetan and De Marchi, Pedro Rafael Martins and de The Bustamante Valles, Flor and Ding, Zhenyu and Doganov, Boyan and Dreosti, Lydia and Duarte, Ricardo and Edusma-Dy, Regina and Emelyanov, Sergey and Erman, Mustafa and Fan, Yun and Fein, Luis and Feng, Jifeng and Fenton, David and Fernandes, Gustavo and Ferreira, Carlos and Franke, Fabio Andre and Freitas, Helano and Fujisaka, Yasuhito and Galindo, Hector and Galvez, Christina and Ganea, Doina and Gil, Nuno and Girotto, Gustavo and Goker, Erdem and Goksel, Tuncay and Gomez Aubin, Gonzalo and Gomez Wolff, Luis and Griph, Hakan and Gumus, Mahmut and Hall, Jacqueline and Hart, Gregory and Havel, Libor and He, Yong and He, Jianxing and ... and KEYNOTE-042 Investigators
The Lancet, ISSN 0140-6736, 05/2019, Volume 393, Issue 10183, pp. 1819 - 1830
First-line pembrolizumab monotherapy improves overall and progression-free survival in patients with untreated metastatic non-small-cell lung cancer with a... 
MEDICINE, GENERAL & INTERNAL | CARBOPLATIN | GEFITINIB | BEVACIZUMAB | CRIZOTINIB | NIVOLUMAB | PACLITAXEL | Genes, erbB-1 - drug effects | Lung Neoplasms - drug therapy | Translocation, Genetic | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Humans | Lung Neoplasms - metabolism | Middle Aged | Far East - epidemiology | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Lung Neoplasms - pathology | Male | Anaplastic Lymphoma Kinase - genetics | Antibodies, Monoclonal, Humanized - administration & dosage | Carcinoma, Non-Small-Cell Lung - secondary | Lung Neoplasms - secondary | Female | Carcinoma, Non-Small-Cell Lung - pathology | Anaplastic Lymphoma Kinase - drug effects | Antibodies, Monoclonal, Humanized - adverse effects | Antibodies, Monoclonal, Humanized - therapeutic use | Drug Administration Schedule | Genes, erbB-1 - genetics | Carcinoma, Non-Small-Cell Lung - metabolism | Disease-Free Survival | B7-H1 Antigen - metabolism | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Neoplasm Metastasis - pathology | Aged | Carcinoma, Non-Small-Cell Lung - drug therapy | Mutation | Chemotherapy | Metastasis | Lung cancer, Non-small cell | Cancer | Slopes | Lung cancer | Oncology | Kinases | Cancer therapies | Metastases | Pembrolizumab | Randomization | Motivation | Platinum | Risk assessment | Population | Translocation | Cell survival | Life expectancy | Epidermal growth factor receptors | Hyperthyroidism | Histology | Hypothyroidism | Survival | Patients | Medical centres | Life span | Interactive systems | PD-L1 protein | Men | Ligands | Tumors | Apoptosis
Journal Article
Turkish Journal of Immunology, ISSN 1301-109X, 01/2014, Volume 2, Issue 1, pp. 16 - 19
Journal Article
Journal of Oncology Pharmacy Practice, ISSN 1078-1552, 12/2019, Volume 25, Issue 8, pp. 2062 - 2063
Journal Article
Journal of Oncology Pharmacy Practice, ISSN 1078-1552, 10/2019, Volume 25, Issue 7, pp. 1658 - 1664
Purpose Studies in the last decade show survival improvement with checkpoint blocker therapy in patients with metastatic malign melanoma. Our purpose was to... 
melanoma | prognostic factors | absolute lymphocytes count | Ipilimumab | TRIALS | LYMPHOCYTE | PHASE-II | CANCER | PEMBROLIZUMAB | ONCOLOGY | ANTIGEN-4 | PHARMACOLOGY & PHARMACY | EXPERIENCE | NIVOLUMAB | CLINICAL-RESPONSE | Therapy | Dehydrogenases | Cell survival | Anemia | Melanoma | Leukocytes (neutrophilic) | Metastasis | Regression analysis | Dehydrogenase | Patients | c-Kit protein | Survival | Metastases | Rank tests | Lymphocytes | Medical prognosis
Journal Article
Japanese Journal of Clinical Oncology, ISSN 0368-2811, 05/2012, Volume 42, Issue 5, pp. 420 - 426
Journal Article
Indian Journal of Surgery, ISSN 0972-2068, 08/2019
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 05/2018, Volume 36, Issue 15_suppl, pp. e21591 - e21591
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 05/2017, Volume 35, Issue 15_suppl, pp. e15055 - e15055
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 05/2017, Volume 35, Issue 15_suppl, pp. e12517 - e12517
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 05/2015, Volume 33, Issue 15_suppl, pp. e20072 - e20072
Journal Article
Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners, 06/2019, p. 1078155219858176
Journal Article
Journal Article
Journal of Palliative Medicine, ISSN 1096-6218, 04/2013, Volume 16, Issue 4, pp. 383 - 390
Journal Article
20.